The Lead Episode 162: A Discussion of Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP Study

Availability

On-Demand

Cost

$0.00

Credit Offered

No Credit Offered

In this episode of The Lead, host Tina Baykaner, MD, MPH, is joined by Christopher Kowalewski, MD, and Marco Perez, MD, to discuss the journal article, Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP Study. Together, they review findings from this secondary analysis of the LOOP Study and explore the relationship between genetic risk and atrial fibrillation screening.

Review the key findings from the secondary analysis of the randomized LOOP Study examining atrial fibrillation screening according to genetic risk.
Discuss the relationship between genetic risk and atrial fibrillation screening as evaluated in the study.
Explore the potential implications of incorporating genetic risk into atrial fibrillation screening strategies.

Podcast Contributors

Host: Tina Baykaner, MD, MPH

Guests:

Christopher Kowalewski, MD

Marco Perez, MD

All relevant financial relationships have been mitigated.

Host and Contributor Disclosure(s):

T. Baykaner

Honoraria/Speaking/Consulting Fee: Volta Medical, Medtronic, Pacemate, Johnson & Johnson, Abbott Medical, Boston Scientific
Research: NIH, Boston Scientific

C. Kowalewski

No relevant disclosures

M. Perez

Ownership/Partnership/Principal: QALY
Honoraria/Speaking/Consulting Fee: Boston Scientific, Biotronik
Research: Apple, Inc.
Other/Stock Options Privately Held

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):

S. Sailor: No relevant financial relationships with ineligible companies to disclose.
E. Downward: No relevant financial relationships with ineligible companies to disclose.